SCHEMBL24322743

SCHEMBL24322743

C[C@@H]1CN(C(=O)CN)CCCN1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC2 Q13490 1/20 0.51
ALDH1A1 P00352 2/20 0.40
LMNA P02545 1/20 0.40
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
MMP1 P03956 3/20 0.37
MMP13 P45452 3/20 0.37
MMP9 P14780 2/20 0.37
CPN1 P15169 1/20 0.33
CPB2 Q96IY4 1/20 0.33
DPP4 P27487 1/20 0.33
PREP P48147 1/20 0.33
FAP Q12884 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
SMYD3 Q9H7B4 3/20 0.33
ADAM17 P78536 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4033981 0.78 BIRC2 (0.49) BIRC2ALDH1A1LMNAMEN1POLB
SCHEMBL25224263 0.78 BIRC2 (0.49) BIRC2ALDH1A1LMNAMEN1POLB
SCHEMBL7498965 0.76 CHRNB2 (0.42) BIRC2CPN1CPB2SMYD3
SCHEMBL6290056 0.75 ALDH1A1 (0.69) ALDH1A1LMNAMEN1POLBMAPT
SCHEMBL28923130 0.73 BIRC2 (0.56) BIRC2ALDH1A1LMNAMEN1POLB
SCHEMBL22828732 0.73 BIRC2 (0.56) BIRC2ALDH1A1LMNAMEN1POLB
SCHEMBL16509278 0.73 BIRC2 (0.56) BIRC2ALDH1A1LMNAMEN1POLB
SCHEMBL28621816 0.73 BIRC2 (0.51) BIRC2ALDH1A1LMNAMEN1KMT2A
SCHEMBL14307630 0.72 DPP4 (0.42) BIRC2DPP4PREPFAPDPP8
SCHEMBL10305143 0.71 ALDH1A1 (0.53) ALDH1A1LMNAMEN1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220122691-A1 HtrA Inhibitors and CagA Inhibitors and Use Thereof Psomagen Inc. (US) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220122691-A1 HtrA Inhibitors and CagA Inhibitors and Use Thereof HTRA1, GIPR, HPN BIRC2 362/4885ALDH1A1 4556/4885LMNA 1889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.